4//SEC Filing
McManus Joseph Richard Jr. 4
Accession 0001062993-25-005944
CIK 0001036262other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 8:12 PM ET
Size
16.6 KB
Accession
0001062993-25-005944
Insider Transaction Report
Form 4
INTEST CORPINTT
McManus Joseph Richard Jr.
Division Pres-Electronic Test
Transactions
- Award
Common Stock
2025-03-17+4,738→ 28,590 total - Award
Common Stock
2025-03-17+4,738→ 33,328 total - Award
Employee Stock Option (right to buy)
2025-03-17+7,954→ 7,954 totalExercise: $7.74Exp: 2035-03-16→ Common Stock (7,954 underlying) - Award
Employee Stock Option (right to buy)
2025-03-17$4.61/sh+2,006$9,248→ 2,006 totalExercise: $7.74Exp: 2035-03-16→ Common Stock (2,006 underlying)
Holdings
- 5,600
Employee Stock Option (right to buy)
Exercise: $11.33Exp: 2034-03-05→ Common Stock (5,600 underlying) - 3,576
Employee Stock Option (right to buy)
Exercise: $16.06Exp: 2033-03-07→ Common Stock (3,576 underlying) - 13,880
Employee Stock Option (right to buy)
Exercise: $8.14Exp: 2032-04-27→ Common Stock (13,880 underlying) - 10,000
Employee Stock Option (right to buy)
Exercise: $13.13Exp: 2031-04-27→ Common Stock (10,000 underlying)
Footnotes (8)
- [F1]These restricted shares were granted pursuant to the inTEST Corporation 2023 Stock Incentive Plan (the "Plan") in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 17, 2026.
- [F2]These performance-based restricted shares were granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest on March 17, 2028 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 7,107.
- [F3]This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 in lieu of an annual base salary merit increase of $9,246. This option will vest in four equal annual installments commencing on March 17, 2026.
- [F4]This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 17, 2026.
- [F5]This option vests in four equal annual installments commencing on March 6, 2025.
- [F6]This option vests in four equal annual installments commencing on March 8, 2024.
- [F7]This option vests in four equal annual installments commencing on April 28, 2023.
- [F8]This option vests in four equal annual installments commencing on April 28, 2022.
Issuer
INTEST CORP
CIK 0001036262
Entity typeother
Related Parties
1- filerCIK 0001918873
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 8:12 PM ET
- Size
- 16.6 KB